ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

Lower Stomach Cancers Increasing In Younger U.S. Whites, Study Finds

May 28, 2010

DRG Regulation Opponents May Have Powerful New Ally

November 25, 1983

Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer

January 25, 2008

In Brief: Ginder To direct Massey Cancer Center; UAB Receives $1 Million for Genetics Chair

August 15, 1997

Statins May Not Have Impact On Testosterone In The Blood

August 31, 2007

In Brief: Shubik, Rhoads, Dixon Affiliations With Industry Lister By House Subcommittee

June 11, 1976